Insulin aspart, recombinant Subcutaneous and Raloxifene Hydrochloride
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Raloxifene Hydrochloride and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: raloxifene
Brand name: Evista
Synonyms: Raloxifene
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Raloxifene Hydrochloride Tablets
- Insulin aspart, recombinant Subcutaneous-Raltegravir
- Insulin aspart, recombinant Subcutaneous-Raltegravir Chewable Tablets
- Insulin aspart, recombinant Subcutaneous-Raltegravir Potassium
- Insulin aspart, recombinant Subcutaneous-Raltegravir Powder for Oral Suspension
- Insulin aspart, recombinant Subcutaneous-Raltegravir Tablets
- Raloxifene Hydrochloride-Insulin degludec
- Raloxifene Hydrochloride-Insulin Degludec (U-100) Prefilled Pens
- Raloxifene Hydrochloride-Insulin Degludec (U-100) Vials
- Raloxifene Hydrochloride-Insulin Degludec (U-200) Prefilled Pens
- Raloxifene Hydrochloride-Insulin degludec and liraglutide
- Raloxifene Hydrochloride-Insulin degludec and liraglutide Subcutaneous